Cite
[Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias].
MLA
de Koning, D. B., et al. “[Thalidomide for the Treatment of Recurrent Gastrointestinal Blood Loss Due to Intestinal Angiodysplasias].” Nederlands Tijdschrift Voor Geneeskunde, vol. 150, no. 36, Sept. 2006, pp. 1994–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17002190&authtype=sso&custid=ns315887.
APA
de Koning, D. B., Drenth, J. P. H., Friederich, P., & Nagengast, F. M. (2006). [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias]. Nederlands Tijdschrift Voor Geneeskunde, 150(36), 1994–1997.
Chicago
de Koning, D B, J P H Drenth, P Friederich, and F M Nagengast. 2006. “[Thalidomide for the Treatment of Recurrent Gastrointestinal Blood Loss Due to Intestinal Angiodysplasias].” Nederlands Tijdschrift Voor Geneeskunde 150 (36): 1994–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17002190&authtype=sso&custid=ns315887.